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expression of four types of connexins (Cxs), including 
Cx32, Cx36, Cx43 and Cx45, and microglial phenotypes 
were analyzed by immunocytochemistry. The H-GJC 
between glioma cells and astrocytes/microglia increased 
after a longer incubation period with a higher number of 
glioma cells. We provided evidence for the direct GJ cou-
pling of microglia and glioma cells under native in  vitro 
conditions. In addition, we exploited this model to evalu-
ate H-GJC after incubation with levetiracetam (LEV) and/
or dexamethasone (DEX). Previous in vitro studies suggest 
that LEV and DEX are frequently used to control seizure 
and edema in glioma. Our findings showed that LEV and/
or DEX decrease the number of heterocellular coupled 
cells significantly. In conclusion, our newly developed 
model demonstrated H-GJC between glioma cells and both 
astrocytes and microglia. The reduced H-GJC by LEV and 
DEX suggests a potential effect of both drugs on glioma 
progression.
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Introduction
Gap junctions (GJs) in astrocytes and glioma cells are 
important channels that contribute to cell-to-cell commu-
nication allowing the exchange of small molecules, ions 
and second messengers, and ensuring the homeostasis in 
multicellular systems [1]. Connexin 43 (Cx43) is the pre-
dominant GJ protein in astrocytes and in glioma cells [1]. 
In addition to gap junctional communication (GJC) within 
a homogenous cell population, astrocytes and glioma cells 
are able to interact with each other through heterocellular 
Abstract Gap junctions (GJs) in astrocytes and glioma 
cells are important channels for cell-to-cell communica-
tion that contribute to homo- and heterocellular coupling. 
According to recent studies, heterocellular gap-junctional 
communication (H-GJC) between glioma cells and their 
surrounding environment enhances glioma progression. 
Therefore, we developed a new in vitro model to examine 
H-GJC between glioma cells, astrocytes and microglia. 
Consequently, F98 rat glioma cells were double-labeled 
with GJ-impermeable (CM-DiI) and GJ-permeable dye 
(calcein AM) and were seeded on unlabeled astrocyte-
microglia co-cultures. Dual whole cell voltage clamp 
recordings were carried out on selected cell pairs to char-
acterize the functional properties of H-GJC in  vitro. The 
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GJ communication (H-GJC) [2, 3] that might support gli-
oma invasion, adhesion and migration [3–5].
Microglia cells are immune cells of the central nerv-
ous system. Ramified microglia represent the predominant 
morphology in the healthy brain, ranging from 5 to 20% 
of the glial cell population [6]. After activation by for-
eign pathogens [7], e.g. glioma cells, microglia proliferate 
and undergo morphological changes towards a rounded 
phagocytic type, express immune molecules and release 
inflammatory mediators [8]. Studies show that microglial 
cells can express Cx43 and communicate with each other 
through GJs under inflammatory conditions [9].
Brain edema and seizures are the most common com-
plications of glioma. Levetiracetam (LEV) and dexa-
methasone (DEX) are commonly administered to control 
these symptoms. Levetiracetam belongs to the second 
generation broad-spectrum anticonvulsants and, due to 
fewer side effects in comparison to other anticonvulsants, 
is preferred as a first-choice drug in glioma-associated sei-
zure [10]. Moreover, LEV shows anti-inflammatory prop-
erties in astrocytic cultures [11, 12]. Dexamethasone is a 
highly potent anti-inflammatory and anti-edematous steroid 
with regulatory effects on microglia morphology [13] and 
glioma cell proliferation [14]. The effects of both drugs 
on homocellular GJC have been separately investigated in 
glioma cells and in primary astrocytes in  vitro [11–13]. 
However, the effects of LEV and DEX on H-GJC have not 
yet been studied. Therefore, we developed an in vitro co-
culture model of astrocyte-microglia-glioma cells to study 
the effects of LEV and DEX on H-GJC. Subsequently, we 
evaluated: (1) the H-GJC between these cells with regard 
to the number and the incubation period of tumor cells in 
microglia-astrocyte cultures; (2) the physiological proper-
ties of heterocellular trans-junctional coupling between 
glioma cells and microglia by the use of dual whole cell 
voltage clamp recordings; (3) Cx32, Cx36, Cx43, Cx45 
expressions on glioma cells; and (4) modulations of micro-
glial morphology by immunocytochemistry.
Materials and methods
Cell culture
Primary astrocyte-microglia cultures were prepared from 
cerebral hemispheres of postnatal (P0–P2) Wistar rats [6]. 
Briefly, cerebellum, meninges and choroid plexus were 
removed and the brains were kept in ice-cold phosphate-
buffered saline (PBS). Following treatment with 0.1% 
trypsin (Invitrogen) for 30  min at 37 °C, centrifugation at 
200×g for 5  min was performed to remove the superna-
tant. After incubation with 1% DNAse I (Serva) for 5 min 
at room temperature (RT), adding cell culture medium 
(Dulbecco’s minimal essential medium, DMEM, with 1% 
glucose, 10% fetal calf serum, 1% nonessential amino acids 
(Invitrogen), penicillin (50 µg/ml), streptomycin (50 µg/ml) 
and glutamine (2  mM)) and centrifugation, they were fil-
tered through a 60-µm nylon mesh and inserted in a plas-
tic tissue-culture flask (Falcon). The flasks were kept in 7% 
CO2, 93% air atmosphere at 37 °C at almost 100% relative 
humidity. This method achieved astrocyte-microglia cul-
tures depleted of other cell types including a negligible 
amount of oligodendrocytes and almost 0% of neurons 
(supplement data from [15]). After 4–5 days, the cultures 
reached about 100% confluent and were placed on poly-L-
lysine-coated glass cover slips (113  mm2) at 70,000 cells 
per well in 24-well plates. F98 rat glioma cells (ATCC®) 
were kept in minimum essential medium (MEM) and 
placed with two different densities of cells (4000 or 40,000) 
on the confluent background of astrocyte-microglia.
Treatment of cultures
Levetiracetam (Sigma, 50 and 100  µg/ml), DEX (Sigma, 
1 and 10  µM) or a combination of both (LEV 50  µg/
ml + DEX 1  µM or LEV 100  µg/ml + DEX 10  µM) were 
applied to the astrocyte-microglial-F98 co-cultures for 
24 h. Concentrations of DEX and LEV were chosen based 
on previous studies and minimum effective concentration 
of each drug [13, 16, 17]. A minimum of six independent 
experiments were studied for each concentration.
Assessment of functional H-GJC
In order to test whether glioma cells, astrocytes and micro-
glia communicate via heterocellular GJs, we used a pre-
loading technique [18, 19] by double labeling F98 cells 
before seeding on astrocyte-microglia cultures in 24-well 
plates. For this purpose, 1 × 106 F98 cells/ml were simul-
taneously incubated with the GJ-permeable dye, calcein 
AM (5  µM; Molecular Probes) and the impermeable cell 
membrane marker Chloromethyl-benzamidodialkylcarbo-
cyanine (Vybrant CM-DiI cell-labeling solution; 5  µl/ml; 
Molecular Probes) at 37 °C for 40  min (under these con-
ditions 100% labeling of glioma cells) [18, 19] and placed 
on unlabeled astrocyte-microglia cultures at the ratio of 
1:45 or 1:4.5 (4000 or 40,000, respectively). The cultures 
were evaluated after 5 or 24 h incubation. The cover slips 
were fixed with 4% paraformaldehyde (PFA) and counter-
stained with ProLong® Gold Antifade Reagent (Molecular 
Probes) to assess H-GJC. We could differentiate labeled 
tumor cells from astrocyte and microglia due to different 
excitation wavelength of calcein and CM-DiI. Moreover, 
we were able to track the dye transfer from tumor cells 
to the surrounding microglia by labeling microglia with 
polyclonal ionized calcium-binding adapter molecule 1 
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antibody (Iba1, 1:300, Wako Pure Chemical Industries). 
The heterocellular coupling index (HCI) was characterized 
by calculating the mean of the number of adjacent calcein-
labeled astrocyte-microglia in the direct surroundings of 
one double-labeled glioma cell. The H-GJC was analyzed 
by fluorescence (Zeiss, Axiovert 35 microscope) and con-
focal scanning microscopy (Zeiss LSM 510, inverted con-
focal microscope) at 630× magnification in a minimum of 
four independent experiments.
Immunocytochemistry
Cover slips with F98 monocultures and mixed astrocyte-
microglia-F98 cell cultures were fixed with 4% PFA and 
incubated in PBS-blocking solution containing 10% horse 
serum and 1% bovine serum albumin. The cover slips were 
treated with poly-/monoclonal rabbit anti-Cx32, anti-Cx36, 
anti-Cx43, anti-Cx45 (1:200, 1:50, 1:2000, 1:50; Zymed, 
Sigma, Chemicon) and polyclonal rabbit anti-Iba1 (1:300) 
and incubated at 4 °C overnight. The next day, the wells 
were incubated with secondary antibodies (1:500, Molec-
ular Probes) including goat anti-rabbit IgG conjugates 
(Alexa fluor® 633) and goat anti-rabbit IgG conjugates 
(Alexa fluor® 488) for 45  min. Immunocytochemically 
labeled cells were counterstained with DAPI (1:2500) to 
quantify the cell numbers. The microglia morphology was 
evaluated in a minimum of six different visual fields on 
each cover slip. Iba1 staining allowed the classification of 
microglia as ramified, intermediate and activated rounded 
phagocytic phenotype [6]. The percentage of each sub-
population was calculated based on the ratio to the whole 
population of microglia.
Electrophysiology
Dual whole cell patch clamp recording
The dual whole cell voltage clamp recordings were used 
to identify macroscopic currents from potentially electri-
cally coupled cultured amoeboid microglia and F98 glioma 
cells. Current recordings took place in a recording chamber 
(volume: 1 ml) mounted on an inverted microscope (Zeiss 
Axiovert; Carl Zeiss AG). Cells were visualized by phase 
contrast microscopy and continuously superfused (4  ml/
min) with oxygenated standard cerebrospinal fluid (accord-
ing to [20, 21]), containing (in mM): 124 NaCl, 2.69 KCl, 
1.25 KH2PO4, 26 NaHCO3, 2 MgSO4, 2 CaCl2 and 10 glu-
cose (Sigma) at RT. Borosilicate glass patch pipettes were 
pulled to an input resistance of 2–5 MΩ. Electrodes of less 
than 5 MΩ and cell pairs with initial conductance less than 
10 nS were used exclusively in the calculations of the gat-
ing properties. Trans-junctional currents (Ij) were meas-
ured in one cell of the pair (clamped to constant voltage), 
while voltage steps (from −120 to 20  mV; 10  mV incre-
ments) of 25  s duration were applied to the neighboring 
cell. All signals were recorded in the voltage clamp mode, 
amplified and digitized at 11 kHz and acquired at 1 kHz for 
analysis by two Axopatch 200B amplifiers (Axon Instru-
ments; Molecular Devices). Series resistance and capaci-
tance were compensated (40–50%) for improved voltage 
clamp control. Data were digitized, displayed and analyzed 
using WinWCP (Strathclyde; Biologic). A 16-bit analogue 
to digital converter (BNC 2110 connected to Ni PCi 6229, 
National Instruments) was used to digitize the signals.
Data analyses and statistics
The differences between the means of the groups were 
analyzed for H-GJC assessment and microglia morpho-
logical study by the one-way ANOVA (F, p), using the 
Bonferroni post hoc test for parametric data or Kruskal-
Wallis and Dunn’s test for nonparametric data. All statis-
tical analyses and graphs were performed with GraphPad 
Prism version 5.00 for Windows (GraphPad Software) or 
OriginPro (Origin Corporation). Sigma Plot 11.0 (Systat 
Software, Chicago, USA) was used to analyze the induced 
effects on membrane current response properties dependent 
on the voltage protocol condition. Comparisons between 
two data sets were carried out using an unpaired nonpara-
metric Mann-Whitney rank sum comparison. The signifi-
cance was set at p < 0.05 and the results were reported as 
mean ± standard error of the mean.
Results
H-GJC between malignant glioma cells and astrocytes/
microglia
The GJ coupling between F98 glioma cells and astrocyte/
microglia was very low in cultures with a low number of 
F98 glioma cells (4000) after 5 or 24 h of incubation (HCI: 
0.1 ± 0.02, n = 4, p = ns). The HCI increased significantly in 
the cultures with higher numbers of F98 cells (40,000) at 
5 h (0.6 ± 0.03, p < 0.001) and 24 h (1.2 ± 0.02, p < 0.001) 
compared to 4000 cells (Fig. 1a). The low number of F98 
cells in the co-cultures showed a very low HCI. Similarly, 
shorter incubation with either a high or low number of F98 
cells did not cause significant coupling between glioma 
cells and their surroundings. Therefore, we utilized mixed 
cultures of 40,000 F98 for the experiments with drug incu-
bations and reported results after 24 h incubation.
Since functional GJC through heterotypic Cx proteins 
on adjacent cells is not likely [22] and different types 
of Cxs are expressed on either astrocytes or microglia, 
we evaluated the expression of Cx43, Cx32, Cx36 and 
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Cx45 in glioma cells to ensure the type of probable GJC 
between these cells. Our results showed that Cx43 was 
the single GJ that was predominantly expressed on F98 
glioma cells.
LEV and/or DEX significantly decreased the H-GJC 
between F98 glioma cells and astrocytes-microglia
The HCI was reduced from 1.1 ± 0.02 in the control group 
to 0.6 ± 0.03 under 1  μM and to 0.6 ± 0.03 under 10  μM 
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DEX (p < 0.0001, n = 6) (Fig. 1b, e). Similarly, the HCI was 
decreased (p < 0.0001, n = 6) significantly from 1.1 ± 0.02 
in the untreated control group to 0.6 ± 0.04 under 50 µg/ml 
LEV and to 0.4 ± 0.04 under 100 µg/ml LEV (p < 0.0001, 
n = 6). The effect of LEV on H-GJC was dose-dependent 
(Fig. 1b, d).
The HCI was decreased (p < 0.0001, n = 6) significantly 
in cultures incubated with 1 μM DEX in combination with 
50 µg/ml LEV (0.6 ± 0.03) compared to the untreated con-
trols (1.2 ± 0.02). Similarly, the combination of 10  μM 
DEX and 100 µg/ml LEV reduced the HCI significantly to 
0.4 ± 0.03 compared to the control (1.2 ± 0.02, p < 0.0001, 
n = 6). The effect of the combination of both drugs on the 
HCI was dose-dependent (Fig. 1c, f).
Voltage dependence of macroscopic junctional currents 
between F98 glioma cells and microglia
In order to evaluate the physiological properties of homo- 
and heterocellular trans-junctional coupling, dual whole 
cell voltage clamp recordings were performed on pairs of 
F98 cells (n = 5) (sample pair Fig. 2a) and amoeboid micro-
glial cells linked to F98 glioma cells (n = 5) (sample pair 
Fig.  2b). One cell (a in Fig.  2) was patched and directed 
to stepwise holding potential depolarization from either 
−120 to +20 mV (10 mV increment; 25 s pulse duration), 
while the neighbor (b in Fig.  2) was kept at −60  mV for 
subsequent trans-junctional current recordings in the whole 
cell configuration for data acquisition. Junctional currents 
(Fig.  2c) were inactivated when trans-junctional voltages 
from −120 to +20 mV were applied for the homocellular 
constellation of coupled F98 cells (Fig. 2a). While the ini-
tial conductance remained unchanged by voltage, the steady 
state conductance decreased for trans-junctional voltage 
values larger than −40  mV. Similar findings were made 
for heterocellular pairs of F98 glioma and microglial cells 
(Fig.  2b, d). The electrophysiological data provides clear 
indication that active shaped microglia are capable of form-
ing electrical synapses with F98 cells in  vitro. This find-
ing is in alignment with the observations from our immu-
nocytochemical studies. Because of the significant reduced 
and very low hetero-cellular coupling after incubation with 
DEX and/or LEV demonstrated by immunocytochemistry, 
as shown in Fig. 1b–f, there are obviously no visible cou-
plings and as a result no available data for dual whole cell 
voltage clamp recordings under DEX/LEV conditions.
Microglial phenotypes in astrocyte-microglia-glioma 
cell co-cultures
The addition of different numbers of F98 tumor cells (4000 
or 40,000 cells) to the astrocyte-microglia co-cultures for 5 
and 24 h did not alter the microglial morphology compared 
to the glioma cell-free control groups (data not shown). The 
entire microglial cell number in both control groups (5 h: 
5 ± 1%; 24  h: 9 ± 1%) was not changed significantly after 
incubation with either 4000 or 40,000 glioma cells for 5 or 
24 h (p = ns; data not shown). Although F98 cells were neg-
ative for Iba-1 in monocultures, F98-glioma cells, which 
were incubated in the presence of astrocytes and microglial 
cells, expressed Iba-1 (Fig. 3).
Discussion
In this study, we developed a new in vitro co-culture model 
to investigate the H-GJC between glioma cells and astro-
cytes/microglia and to evaluate the effects of DEX and 
LEV on heterocellular coupling.
Functional hetero-cellular gap-junctional coupling 
between glioma cells and astrocytes/microglia
Since GJs are implicated in cell growth and differentiation, 
modulations of GJs on glioma cells have been investigated 
in several experiments [23, 24]. Previous studies demon-
strated the heterocellular coupling between astrocytes and 
glioma cells [2, 3]; however, H-GJC has not been studied 
in the presence of microglia in  vitro. Our in  vitro study 
showed that the number of F98 cells is an essential factor 
for H-GJC. A reasonable answer to this effect might be the 
accumulating effect of soluble factors, such as cytokines 
from F98 cells, which is obviously enhanced with increas-
ing cell numbers in the culture.
Our results showed that Cx43 is the predominant Cx 
in F98 cells. On the other hand, despite the controversial 
studies about the expression of Cx43 on microglia [9, 25], 
the expression of Cx32 and Cx36 on microglia has been 
shown previously [26]. Using dual whole cell patch clamp 
recording and immunocytochemistry, we demonstrated that 
Fig. 1  Heterocellular coupling of F98 glioma cell line with astro-
cytes/microglia. a Significant difference of H-GJC in cultures with 
high (40,000) and low (4000) F98 cells after 5 or 24  h incubation. 
b, c H-GJC between F98 glioma cells and astrocytes/microglia was 
decreased significantly under LEV and/or DEX. Data were collected 
by at least four independent experiments and tested with Kruskal-
Wallis and Dunn’s post hoc test, *p < 0.05, **p < 0.01, ***p < 0.001. 
LEV levetiracetam, DEX dexamethasone, HCI heterocellular cou-
pling index (number of recipient astrocytes/microglia per one F98 
tumor cell), 1 DEX 1  μM + LEV 50  µg/ml, 2 DEX 10  μM + LEV 
100 µg/ml. Units for 50 and 100 LEV in b are not indicated (µg/ml). 
d–f Reduced heterocellular coupling after incubation of the astrocyte-
microglia-F98 cultures with DEX and/or LEV is demonstrated by 
immunocytochemistry. Functional H-GJC is visualized by transfer of 
calcein from CM-DiI-labeled F98 donor cells to unlabeled recipient 
astrocytes/microglia. Cell nuclei were detected by applying DAPI. 
Calcein: green, CM-DiI: red, Cx43 (not in all pictures visible): pink, 
DAPI: blue, merged picture
◂
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microglia are capable of forming electrical synapses with 
F98 cells in  vitro. We believe that Cx43 is the major GJ 
in H-GJC between microglia and F98 cells in our study 
because: (1) Cx43 is the predominant GJs on F98 cells, 
whereas the expression of Cx32, Cx36 and Cx45 in F98 
glioma cells were negative (data not shown), (2) only 
Fig. 2  Homo- and heterocel-
lular gap junction (H-GJC)-
based coupling properties 
characterized in dual whole cell 
patch clamp recordings in the 
voltage clamp mode. a Sample 
pair of F98 glioma cells (F98). 
b Amoeboid microglia (MG) 
coupled to an F98 glioma (F98) 
cell during recording. c, d 
Corresponding trans-junctional 
current responses of the sample 
pairs in a and b following 
stepwise holding potential 
depolarization from −120 to 
+20 mV condition (each 10 mV 
increment; 25 s pulse duration) 
while the neighbor (b) was kept 
at −60 mV
Fig. 3  H-GJC between F98 
cells and microglia in the 
cultures of astrocyte-microlgia-
F98 cells. Microglial cells were 
marked with Iba1. Functional 
H-GJC is visualized by transfer 
of calcein from CM-DiI-labeled 
donor cells to unlabeled recipi-
ent astrocytes and microglia. 
Cell nuclei were detected by 
applying DAPI. Note that F98 
cells express Iba1. a Calcein 
green. b CM-DiI red. c Iba1 
pink. d DAPI blue, merged 
picture
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homotypical GJCs are functional [22], and (3) the trans-
junctional current amplitudes, conductance and activation 
pattern give rise to Cx43-based properties.
Some F98 tumor cells showed significantly increased 
Iba-1 immunoreactivity after incubation with astrocyte-
microglia co-cultures compared to the monoculture of 
tumor cells. Since GJs allow the rapid transfer of gene frag-
ments through a cellular network [27, 28], such DNA-trans-
fer between microglia and glioma cells may contribute to 
Iba-1 expression in glioma cells. This transfer could be one 
of the immune escape mechanisms that leads to incapac-
ity of the immune system to detect and reject transformed 
cells. The H-GJC between glioma cells and microglia 
might represent one of the underlying mechanisms con-
tributing to glioma cell migration [29]. These observations 
could be useful in the development of novel immunother-
apy strategies.
DEX and LEV decreased H-GJC between F98 cells 
and astrocytes/microglia
Dexamethasone is commonly used as symptomatic ther-
apy for tumor-associated edema [30] and LEV is applied 
as one of the first therapeutic choices for seizures in gli-
oma. However, little is known about their probable effects 
on glioma cells. Previous studies have shown that DEX 
inhibits proliferation of glioma cells [14] and reduces both 
their migration and invasion [31]. Although the mechanism 
of such effects is not well understood, probable mecha-
nisms, such as reduced matrix metalloproteinase-2 secre-
tion from glioma cells [31], decreased Cx43 expression 
in glioma cells [13] or reduced microglia recruitment and 
activation [32], have been proposed. Based on our results, 
decreased H-GJC between F98 cells and astrocytes/micro-
glia might be a new mechanism of effect of DEX in glioma 
progression.
In addition to anticonvulsant activity, LEV can contrib-
ute a positive effect to the specific glioma treatment [10] 
and exhibits anti-inflammatory properties in  vitro [11]. 
Taking into account that GJC has been implicated in sei-
zure pathogenesis, disconnection of H-GJC caused by LEV 
and/or DEX could have a possible role in reducing seizure 
activity.
We could not detect specifically whether HCI reduction 
by LEV and DEX originated from the H-GJC of astrocyte-
F98 or microglia-F98 cells. However, since astrocytes out-
number microglia in our co-cultures, we speculated that the 
reduction of H-GJC by LEV and DEX reflects astrocyte-
F98 GJC. Our findings generally suggest an additional 
mechanism besides anti-inflammatory and anticonvulsant 
activity through which DEX and LEV might affect seizures 
and glioma progression as well.
Conclusion
We developed a novel in  vitro co-culture model of astro-
cytes, microglia, and glioma cells to study the effects of 
DEX and LEV on H-GJC between glioma cells and astro-
cytes-microglia co-cultures. We demonstrated the direct 
functional H-GJC between glioma cells and microglia. In 
our study, DEX and LEV decreased H-GJC between gli-
oma cells and astrocytes/microglia. This new aspect could 
point to a potential effect of DEX and LEV on glioma 
migration and seizure activity. Additional studies using 
clonal variation in tumor genicity and cell growth, and 
in vivo animal models are required to evaluate the impact 
of current findings under DEX and LEV treatment. Our 
model allows the testing of aspects of glioma in response 
to frequently applied drugs. Additionally, it can be used in 
the relevant research area to identify the cell biological pro-
cesses imposed by glioma cells.
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